19/155 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Ayyadevara S, Balasubramaniam M, Parcon PA, Barger SW, Griffin WS, Alla R, Tackett AJ, Mackintosh SG, Petricoin E, Zhou W, Shmookler Reis RJ. Proteins that mediate protein aggregation and cytotoxicity distinguish Alzheimer's hippocampus from normal controls. Aging Cell. PMID 27448508 DOI: 10.1111/Acel.12501  0.58
2015 Aboud O, Parcon PA, DeWall KM, Liu L, Mrak RE, Griffin WS. Aging, Alzheimer's, and APOE genotype influence the expression and neuronal distribution patterns of microtubule motor protein dynactin-P50. Frontiers in Cellular Neuroscience. 9: 103. PMID 25859183 DOI: 10.3389/Fncel.2015.00103  0.585
2015 Thal DR, von Arnim CA, Griffin WS, Mrak RE, Walker L, Attems J, Arzberger T. Frontotemporal lobar degeneration FTLD-tau: preclinical lesions, vascular, and Alzheimer-related co-pathologies. Journal of Neural Transmission (Vienna, Austria : 1996). 122: 1007-18. PMID 25556950 DOI: 10.1007/S00702-014-1360-6  0.332
2008 Barger SW, DeWall KM, Liu L, Mrak RE, Griffin WS. Relationships between expression of apolipoprotein E and beta-amyloid precursor protein are altered in proximity to Alzheimer beta-amyloid plaques: potential explanations from cell culture studies. Journal of Neuropathology and Experimental Neurology. 67: 773-83. PMID 18648325 DOI: 10.1097/Nen.0B013E318180Ec47  0.345
2008 Thal DR, Griffin WS, Braak H. Parenchymal and vascular Abeta-deposition and its effects on the degeneration of neurons and cognition in Alzheimer's disease. Journal of Cellular and Molecular Medicine. 12: 1848-62. PMID 18624777 DOI: 10.1111/j.1582-4934.2008.00411.x  0.328
2005 Thal DR, Schultz C, Botez G, Del Tredici K, Mrak RE, Griffin WS, Wiestler OD, Braak H, Ghebremedhin E. The impact of argyrophilic grain disease on the development of dementia and its relationship to concurrent Alzheimer's disease-related pathology. Neuropathology and Applied Neurobiology. 31: 270-9. PMID 15885064 DOI: 10.1111/j.1365-2990.2005.00635.x  0.327
1998 Griffin WS, Sheng JG, McKenzie JE, Royston MC, Gentleman SM, Brumback RA, Cork LC, Del Bigio MR, Roberts GW, Mrak RE. Life-long overexpression of S100beta in Down's syndrome: implications for Alzheimer pathogenesis. Neurobiology of Aging. 19: 401-5. PMID 9880042 DOI: 10.1016/S0197-4580(98)00074-8  0.312
1998 Li Y, Wang J, Sheng JG, Liu L, Barger SW, Jones RA, Van Eldik LJ, Mrak RE, Griffin WS. S100 beta increases levels of beta-amyloid precursor protein and its encoding mRNA in rat neuronal cultures. Journal of Neurochemistry. 71: 1421-8. PMID 9751173 DOI: 10.1046/J.1471-4159.1998.71041421.X  0.325
1998 Sheng JG, Zhou XQ, Mrak RE, Griffin WS. Progressive neuronal injury associated with amyloid plaque formation in Alzheimer disease. Journal of Neuropathology and Experimental Neurology. 57: 714-7. PMID 9690675  0.304
1994 Sheng JG, Boop FA, Mrak RE, Griffin WS. Increased neuronal beta-amyloid precursor protein expression in human temporal lobe epilepsy: association with interleukin-1 alpha immunoreactivity. Journal of Neurochemistry. 63: 1872-9. PMID 7931344 DOI: 10.1046/J.1471-4159.1994.63051872.X  0.323
1981 Pacheco MF, Woodward DJ, McKelvy JF, Griffin WS. Trh in the rat cerebellum: II. Uptake by cerebellar slices. Peptides. 2: 283-8. PMID 6795609 DOI: 10.1016/S0196-9781(81)80120-9  0.474
1981 Pacheco MF, McKelvy JF, Woodward DJ, Loudes C, Joseph-Bravo P, Krulich L, Griffin WS. TRH in the rat cerebellum: I. Distribution and concentration. Peptides. 2: 277-82. PMID 6795608 DOI: 10.1016/S0196-9781(81)80119-2  0.444
1980 Griffin WS, Eriksson MA, del Cerro M, Woodward DJ, Stampfer N. Naturally occurring alterations of cortical layers surrounding the fissura prima of rat cerebellum. The Journal of Comparative Neurology. 192: 109-18. PMID 7410606 DOI: 10.1002/cne.901920107  0.463
1978 Griffin WS, Head JR, Woodward DJ, Carrol C. Graft-versus-host disease impairs cerebellar growth. Nature. 275: 315-7. PMID 692707 DOI: 10.1038/275315a0  0.432
1978 Griffin WS, Woodward DJ, Chanda R. Quantification of cell death in developing cerebellum by a 14C tracer method. Brain Research Bulletin. 3: 369-72. PMID 318207 DOI: 10.1016/0361-9230(78)90105-3  0.483
1978 Griffin WS, Woodward DJ, Chanda R. DNA synthetic ability in cerebella from temperature and handling stressed neonatal rats. Brain Research Bulletin. 3: 365-7. PMID 318206 DOI: 10.1016/0361-9230(78)90104-1  0.452
1977 Griffin WS, Woodward DJ, Chanda R. Malnutrition-induced alterations of developing Purkinje cells. Experimental Neurology. 56: 298-311. PMID 885191 DOI: 10.1016/0014-4886(77)90349-1  0.442
1977 Griffin WS, Woodward DJ, Chanda R. Malnutrition and brain development: cerebellar weight, DNA, RNA, protein and histological correlations. Journal of Neurochemistry. 28: 1269-79. PMID 874489 DOI: 10.1111/J.1471-4159.1977.Tb12320.X  0.492
1975 Chanda R, Woodward DJ, Griffin WS. Deoxyribonucleases in developing and adult rat cerebellum: transient and long duration actions of methylazoxymethanol. Journal of Neurochemistry. 24: 723-7. PMID 235599 DOI: 10.1111/J.1471-4159.1975.Tb03855.X  0.451
Low-probability matches (unlikely to be authored by this person)
2010 Thal DR, Papassotiropoulos A, Saido TC, Griffin WS, Mrak RE, Kölsch H, Del Tredici K, Attems J, Ghebremedhin E. Capillary cerebral amyloid angiopathy identifies a distinct APOE epsilon4-associated subtype of sporadic Alzheimer's disease. Acta Neuropathologica. 120: 169-83. PMID 20535486 DOI: 10.1007/S00401-010-0707-9  0.295
1998 Sheng JG, Mrak RE, Griffin WS. Progressive neuronal DNA damage associated with neurofibrillary tangle formation in Alzheimer disease. Journal of Neuropathology and Experimental Neurology. 57: 323-8. PMID 9600224  0.292
2001 Sheng JG, Jones RA, Zhou XQ, McGinness JM, Van Eldik LJ, Mrak RE, Griffin WS. Interleukin-1 promotion of MAPK-p38 overexpression in experimental animals and in Alzheimer's disease: potential significance for tau protein phosphorylation. Neurochemistry International. 39: 341-8. PMID 11578769 DOI: 10.1016/S0197-0186(01)00041-9  0.292
1994 Sheng JG, Mrak RE, Griffin WS. S100 beta protein expression in Alzheimer disease: potential role in the pathogenesis of neuritic plaques. Journal of Neuroscience Research. 39: 398-404. PMID 7884819 DOI: 10.1002/jnr.490390406  0.292
2008 Núñez E, Benito C, Tolón RM, Hillard CJ, Griffin WS, Romero J. Glial expression of cannabinoid CB(2) receptors and fatty acid amide hydrolase are beta amyloid-linked events in Down's syndrome. Neuroscience. 151: 104-10. PMID 18068305 DOI: 10.1016/j.neuroscience.2007.10.029  0.288
2008 Thal DR, Griffin WS, de Vos RA, Ghebremedhin E. Cerebral amyloid angiopathy and its relationship to Alzheimer's disease. Acta Neuropathologica. 115: 599-609. PMID 18369648 DOI: 10.1007/s00401-008-0366-2  0.288
2013 Aboud O, Mrak RE, Boop FA, Griffin WS. Epilepsy: neuroinflammation, neurodegeneration, and APOE genotype. Acta Neuropathologica Communications. 1: 41. PMID 24252240 DOI: 10.1186/2051-5960-1-41  0.287
1999 Chan SL, Griffin WS, Mattson MP. Evidence for caspase-mediated cleavage of AMPA receptor subunits in neuronal apoptosis and Alzheimer's disease. Journal of Neuroscience Research. 57: 315-23. PMID 10412022 DOI: 10.1002/(Sici)1097-4547(19990801)57:3<315::Aid-Jnr3>3.0.Co;2-#  0.286
2011 Griffin WS. Alzheimer's - Looking beyond plaques. F1000 Medicine Reports. 3: 24. PMID 22162727 DOI: 10.3410/M3-24  0.286
1999 Zhu SG, Sheng JG, Jones RA, Brewer MM, Zhou XQ, Mrak RE, Griffin WS. Increased interleukin-1beta converting enzyme expression and activity in Alzheimer disease. Journal of Neuropathology and Experimental Neurology. 58: 582-7. PMID 10374748  0.286
1998 Sheng JG, Griffin WS, Royston MC, Mrak RE. Distribution of interleukin-1-immunoreactive microglia in cerebral cortical layers: implications for neuritic plaque formation in Alzheimer's disease. Neuropathology and Applied Neurobiology. 24: 278-83. PMID 9775393  0.281
1998 Griffin WS, Sheng JG, Royston MC, Gentleman SM, McKenzie JE, Graham DI, Roberts GW, Mrak RE. Glial-neuronal interactions in Alzheimer's disease: the potential role of a 'cytokine cycle' in disease progression. Brain Pathology (Zurich, Switzerland). 8: 65-72. PMID 9458167 DOI: 10.1111/J.1750-3639.1998.Tb00136.X  0.281
2013 Thal DR, von Arnim C, Griffin WS, Yamaguchi H, Mrak RE, Attems J, Upadhaya AR. Pathology of clinical and preclinical Alzheimer's disease. European Archives of Psychiatry and Clinical Neuroscience. 263: S137-45. PMID 24077890 DOI: 10.1007/S00406-013-0449-5  0.279
2005 Thal DR, Capetillo-Zarate E, Schultz C, Rüb U, Saido TC, Yamaguchi H, Haass C, Griffin WS, Del Tredici K, Braak H, Ghebremedhin E. Apolipoprotein E co-localizes with newly formed amyloid beta-protein (Abeta) deposits lacking immunoreactivity against N-terminal epitopes of Abeta in a genotype-dependent manner. Acta Neuropathologica. 110: 459-71. PMID 16195918 DOI: 10.1007/S00401-005-1053-1  0.276
1995 Griffin WS, Sheng JG, Roberts GW, Mrak RE. Interleukin-1 expression in different plaque types in Alzheimer's disease: significance in plaque evolution. Journal of Neuropathology and Experimental Neurology. 54: 276-81. PMID 7876895  0.274
1996 Sheng JG, Mrak RE, Griffin WS. Apolipoprotein E distribution among different plaque types in Alzheimer's disease: implications for its role in plaque progression. Neuropathology and Applied Neurobiology. 22: 334-41. PMID 8875468  0.272
2000 Sheng JG, Mrak RE, Bales KR, Cordell B, Paul SM, Jones RA, Woodward S, Zhou XQ, McGinness JM, Griffin WS. Overexpression of the neuritotrophic cytokine S100beta precedes the appearance of neuritic beta-amyloid plaques in APPV717F mice. Journal of Neurochemistry. 74: 295-301. PMID 10617132 DOI: 10.1046/J.1471-4159.2000.0740295.X  0.27
2000 Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, Cooper NR, Eikelenboom P, Emmerling M, Fiebich BL, Finch CE, Frautschy S, Griffin WS, Hampel H, Hull M, et al. Inflammation and Alzheimer's disease. Neurobiology of Aging. 21: 383-421. PMID 10858586 DOI: 10.1016/S0197-4580(00)00124-X  0.269
2006 Griffin WS, Liu L, Li Y, Mrak RE, Barger SW. Interleukin-1 mediates Alzheimer and Lewy body pathologies. Journal of Neuroinflammation. 3: 5. PMID 16542445 DOI: 10.1186/1742-2094-3-5  0.265
2004 Liu DG, He SR, Zhang W, Cui D, Li Y, Griffin WS. [Relationship between apoptosis of neurons and microglia activation in Alzheimer's disease]. Zhonghua Bing Li Xue Za Zhi Chinese Journal of Pathology. 33: 404-7. PMID 15498206  0.265
2000 Sheng JG, Zhu SG, Jones RA, Griffin WS, Mrak RE. Interleukin-1 promotes expression and phosphorylation of neurofilament and tau proteins in vivo. Experimental Neurology. 163: 388-91. PMID 10833312 DOI: 10.1006/exnr.2000.7393  0.265
1996 Mrak RE, Sheng JG, Griffin WS. Correlation of astrocytic S100 beta expression with dystrophic neurites in amyloid plaques of Alzheimer's disease. Journal of Neuropathology and Experimental Neurology. 55: 273-9. PMID 8786385  0.265
2002 Griffin WS, Mrak RE. Interleukin-1 in the genesis and progression of and risk for development of neuronal degeneration in Alzheimer's disease. Journal of Leukocyte Biology. 72: 233-8. PMID 12149413  0.264
1997 Sheng JG, Mrak RE, Griffin WS. Neuritic plaque evolution in Alzheimer's disease is accompanied by transition of activated microglia from primed to enlarged to phagocytic forms. Acta Neuropathologica. 94: 1-5. PMID 9224523 DOI: 10.1007/S004010050664  0.26
1995 Mrak RE, Sheng JG, Griffin WS. Glial cytokines in Alzheimer's disease: review and pathogenic implications. Human Pathology. 26: 816-23. PMID 7635444 DOI: 10.1016/0046-8177(95)90001-2  0.256
1997 Ito K, Ishikawa Y, Skinner RD, Mrak RE, Morrison-Bogorad M, Mukawa J, Griffin WS. Lesioning of the inferior olive using a ventral surgical approach. Characterization of temporal and spatial astrocytic responses at the lesion site and in cerebellum. Molecular and Chemical Neuropathology / Sponsored by the International Society For Neurochemistry and the World Federation of Neurology and Research Groups On Neurochemistry and Cerebrospinal Fluid. 31: 245-64. PMID 9336767 DOI: 10.1007/Bf02815128  0.254
1992 Azmitia EC, Griffin WS, Marshak DR, Van Eldik LJ, Whitaker-Azmitia PM. S100 beta and serotonin: a possible astrocytic-neuronal link to neuropathology of Alzheimer's disease. Progress in Brain Research. 94: 459-73. PMID 1287730 DOI: 10.1016/S0079-6123(08)61773-2  0.251
2008 Griffin WS. Perispinal etanercept: potential as an Alzheimer therapeutic. Journal of Neuroinflammation. 5: 3. PMID 18186919 DOI: 10.1186/1742-2094-5-3  0.251
2010 Griffin WS. Excess betaCTF, not Abeta: the culprit in Alzheimer-related endocytic dysfunction. Proceedings of the National Academy of Sciences of the United States of America. 107: 1263-4. PMID 20133888 DOI: 10.1073/pnas.0913922107  0.251
2001 Mrak RE, Griffin WS. Interleukin-1, neuroinflammation, and Alzheimer's disease. Neurobiology of Aging. 22: 903-8. PMID 11754997  0.251
1982 Griffin WS, Crom EN, Head JR. Manipulation of brain DNA synthesis is achieved by using a systemic immunological disease. Proceedings of the National Academy of Sciences of the United States of America. 79: 4783-5. PMID 6956888  0.249
2010 Griffin WS, Barger SW. Neuroinflammatory Cytokines-The Common Thread in Alzheimer's Pathogenesis. Us Neurology. 6: 19-27. PMID 22408651  0.248
2000 Mrak RE, Griffin WS. Interleukin-1 and the immunogenetics of Alzheimer disease. Journal of Neuropathology and Experimental Neurology. 59: 471-6. PMID 10850859  0.247
2001 Peskind ER, Griffin WS, Akama KT, Raskind MA, Van Eldik LJ. Cerebrospinal fluid S100B is elevated in the earlier stages of Alzheimer's disease. Neurochemistry International. 39: 409-13. PMID 11578776 DOI: 10.1016/S0197-0186(01)00048-1  0.244
1990 Griffin WS, Ling C, White CL, Morrison-Bogorad M. Polyadenylated messenger RNA in paired helical filament-immunoreactive neurons in Alzheimer disease. Alzheimer Disease and Associated Disorders. 4: 69-78. PMID 1972628  0.24
2003 Li Y, Liu L, Barger SW, Griffin WS. Interleukin-1 mediates pathological effects of microglia on tau phosphorylation and on synaptophysin synthesis in cortical neurons through a p38-MAPK pathway. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 1605-11. PMID 12629164 DOI: 10.1523/Jneurosci.23-05-01605.2003  0.238
1999 Graham DI, Gentleman SM, Nicoll JA, Royston MC, McKenzie JE, Roberts GW, Mrak RE, Griffin WS. Is there a genetic basis for the deposition of beta-amyloid after fatal head injury? Cellular and Molecular Neurobiology. 19: 19-30. PMID 10079962 DOI: 10.1023/A:1006956306099  0.237
2001 Sheng JG, Mrak RE, Jones RA, Brewer MM, Zhou XQ, McGinness J, Woodward S, Bales K, Paul SM, Cordell B, Griffin WS. Neuronal DNA damage correlates with overexpression of interleukin-1beta converting enzyme in APPV717F mice. Neurobiology of Aging. 22: 895-902. PMID 11754996 DOI: 10.1016/S0197-4580(01)00298-6  0.235
2004 Li Y, Liu L, Liu D, Woodward S, Barger SW, Mrak RE, Griffin WS. Microglial activation by uptake of fDNA via a scavenger receptor. Journal of Neuroimmunology. 147: 50-5. PMID 14741427 DOI: 10.1016/J.Jneuroim.2003.10.043  0.234
1995 Sheng JG, Mrak RE, Griffin WS. Microglial interleukin-1 alpha expression in brain regions in Alzheimer's disease: correlation with neuritic plaque distribution. Neuropathology and Applied Neurobiology. 21: 290-301. PMID 7494597  0.233
1980 Griffin WS, Eriksson MA, Crom EN, Head JR. Malformation of Purkinje cell dendrites induced by graft-versus-host disease. Brain Research Bulletin. 5: 673-8. PMID 7470938  0.232
2016 Itzhaki RF, Lathe R, Balin BJ, Ball MJ, Bearer EL, Braak H, Bullido MJ, Carter C, Clerici M, Cosby SL, Del Tredici K, Field H, Fulop T, Grassi C, Griffin WS, et al. Microbes and Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 26967229 DOI: 10.3233/Jad-160152  0.227
1989 Griffin WS, Stanley LC, Ling C, White L, MacLeod V, Perrot LJ, White CL, Araoz C. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proceedings of the National Academy of Sciences of the United States of America. 86: 7611-5. PMID 2529544  0.227
2000 Li Y, Liu L, Kang J, Sheng JG, Barger SW, Mrak RE, Griffin WS. Neuronal-glial interactions mediated by interleukin-1 enhance neuronal acetylcholinesterase activity and mRNA expression. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 20: 149-55. PMID 10627591 DOI: 10.1523/Jneurosci.20-01-00149.2000  0.224
1996 Mrak RE, Griffin WS. Role of Activated Glia and of Glial Cytokines in Alzheimer's Disease: A Review. Eos (Rome, Italy). 16: 80-84. PMID 24478534  0.222
2011 Liu L, Aboud O, Jones RA, Mrak RE, Griffin WS, Barger SW. Apolipoprotein E expression is elevated by interleukin 1 and other interleukin 1-induced factors. Journal of Neuroinflammation. 8: 175. PMID 22171672 DOI: 10.1186/1742-2094-8-175  0.221
2007 Mrak RE, Griffin WS. Dementia with Lewy bodies: Definition, diagnosis, and pathogenic relationship to Alzheimer's disease. Neuropsychiatric Disease and Treatment. 3: 619-25. PMID 19300591  0.219
1994 Griffin WS, Sheng JG, Gentleman SM, Graham DI, Mrak RE, Roberts GW. Microglial interleukin-1 alpha expression in human head injury: correlations with neuronal and neuritic beta-amyloid precursor protein expression. Neuroscience Letters. 176: 133-6. PMID 7830934 DOI: 10.1016/0304-3940(94)90066-3  0.213
1997 Sheng JG, Mrak RE, Griffin WS. Glial-neuronal interactions in Alzheimer disease: progressive association of IL-1alpha+ microglia and S100beta+ astrocytes with neurofibrillary tangle stages. Journal of Neuropathology and Experimental Neurology. 56: 285-90. PMID 9056542  0.212
1981 Griffin WS, Crom EN, Head JR. Alterations in cerebellar germinal cell division induced by graft-versus-host disease. The Journal of Comparative Neurology. 203: 91-101. PMID 7309918 DOI: 10.1002/cne.902030108  0.206
1994 Van Eldik LJ, Griffin WS. S100 beta expression in Alzheimer's disease: relation to neuropathology in brain regions. Biochimica Et Biophysica Acta. 1223: 398-403. PMID 7918676 DOI: 10.1016/0167-4889(94)90101-5  0.205
2004 Wu SZ, Bodles AM, Porter MM, Griffin WS, Basile AS, Barger SW. Induction of serine racemase expression and D-serine release from microglia by amyloid beta-peptide. Journal of Neuroinflammation. 1: 2. PMID 15285800 DOI: 10.1186/1742-2094-1-2  0.202
2000 Griffin WS, Nicoll JA, Grimaldi LM, Sheng JG, Mrak RE. The pervasiveness of interleukin-1 in alzheimer pathogenesis: a role for specific polymorphisms in disease risk. Experimental Gerontology. 35: 481-7. PMID 10959036  0.197
1987 Morrison MR, Pardue S, Maschoff K, Griffin WS, White CL, Gilbert J, Roses A. Brain messenger RNA levels and ribonuclease activity in Alzheimer's disease. Biochemical Society Transactions. 15: 133-4. PMID 3556737  0.196
2005 Mrak RE, Griffin WS. Potential inflammatory biomarkers in Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 8: 369-75. PMID 16556968  0.194
2013 Griffin WS. Neuroinflammatory cytokine signaling and Alzheimer's disease. The New England Journal of Medicine. 368: 770-1. PMID 23425171 DOI: 10.1056/NEJMcibr1214546  0.193
1999 Kyosseva SV, Elbein AD, Griffin WS, Mrak RE, Lyon M, Karson CN. Mitogen-activated protein kinases in schizophrenia. Biological Psychiatry. 46: 689-96. PMID 10472421 DOI: 10.1016/S0006-3223(99)00104-3  0.193
2004 Streit WJ, Mrak RE, Griffin WS. Microglia and neuroinflammation: a pathological perspective. Journal of Neuroinflammation. 1: 14. PMID 15285801 DOI: 10.1186/1742-2094-1-14  0.191
1992 Marshak DR, Pesce SA, Stanley LC, Griffin WS. Increased S100 beta neurotrophic activity in Alzheimer's disease temporal lobe. Neurobiology of Aging. 13: 1-7. PMID 1371849 DOI: 10.1016/0197-4580(92)90002-F  0.187
2013 Wilcock DM, Griffin WS. Down's syndrome, neuroinflammation, and Alzheimer neuropathogenesis. Journal of Neuroinflammation. 10: 84. PMID 23866266 DOI: 10.1186/1742-2094-10-84  0.186
1996 Sheng JG, Mrak RE, Rovnaghi CR, Kozlowska E, Van Eldik LJ, Griffin WS. Human brain S100 beta and S100 beta mRNA expression increases with age: pathogenic implications for Alzheimer's disease. Neurobiology of Aging. 17: 359-63. PMID 8725896 DOI: 10.1016/0197-4580(96)00037-1  0.186
1982 Griffin WS, Crom EN, Cowan GM, Head JR. Immunotherapy of graft versus host disease with specific alloantiserum: restoration of cerebellar development in infant rats. Proceedings of the Royal Society of London. Series B, Biological Sciences. 215: 289-98. PMID 6127709  0.181
2007 Mrak RE, Griffin WS. Common inflammatory mechanisms in Lewy body disease and Alzheimer disease. Journal of Neuropathology and Experimental Neurology. 66: 683-6. PMID 17882012 DOI: 10.1097/nen.0b013e31812503e1  0.179
1995 Griffin WS, Yeralan O, Sheng JG, Boop FA, Mrak RE, Rovnaghi CR, Burnett BA, Feoktistova A, Van Eldik LJ. Overexpression of the neurotrophic cytokine S100 beta in human temporal lobe epilepsy. Journal of Neurochemistry. 65: 228-33. PMID 7790864  0.178
2011 Zawada WM, Banninger GP, Thornton J, Marriott B, Cantu D, Rachubinski AL, Das M, Griffin WS, Jones SM. Generation of reactive oxygen species in 1-methyl-4-phenylpyridinium (MPP+) treated dopaminergic neurons occurs as an NADPH oxidase-dependent two-wave cascade. Journal of Neuroinflammation. 8: 129. PMID 21975039 DOI: 10.1186/1742-2094-8-129  0.176
1983 Griffin WS, Alejos M, Nilaver G, Morrison MR. Brain protein and messenger RNA identification in the same cell. Brain Research Bulletin. 10: 597-601. PMID 6347344  0.175
2014 Pey P, Pearce RK, Kalaitzakis ME, Griffin WS, Gentleman SM. Phenotypic profile of alternative activation marker CD163 is different in Alzheimer's and Parkinson's disease. Acta Neuropathologica Communications. 2: 21. PMID 24528486 DOI: 10.1186/2051-5960-2-21  0.173
1997 Gentleman SM, Greenberg BD, Savage MJ, Noori M, Newman SJ, Roberts GW, Griffin WS, Graham DI. A beta 42 is the predominant form of amyloid beta-protein in the brains of short-term survivors of head injury. Neuroreport. 8: 1519-22. PMID 9172166  0.172
1983 Hoot GP, Head JR, Griffin WS. Increased free plasma corticosterone and adrenal hyperactivity associated with graft-versus-host disease. Transplantation. 35: 478-83. PMID 6845412  0.171
2003 Culpan D, MacGowan SH, Ford JM, Nicoll JA, Griffin WS, Dewar D, Cairns NJ, Hughes A, Kehoe PG, Wilcock GK. Tumour necrosis factor-alpha gene polymorphisms and Alzheimer's disease. Neuroscience Letters. 350: 61-5. PMID 12962917 DOI: 10.1016/S0304-3940(03)00854-1  0.17
1998 Sheng JG, Mrak RE, Griffin WS. Enlarged and phagocytic, but not primed, interleukin-1 alpha-immunoreactive microglia increase with age in normal human brain. Acta Neuropathologica. 95: 229-34. PMID 9542587 DOI: 10.1007/S004010050792  0.169
2000 Li Y, Barger SW, Liu L, Mrak RE, Griffin WS. S100beta induction of the proinflammatory cytokine interleukin-6 in neurons. Journal of Neurochemistry. 74: 143-50. PMID 10617115 DOI: 10.1046/J.1471-4159.2000.0740143.X  0.169
2005 Liu L, Li Y, Van Eldik LJ, Griffin WS, Barger SW. S100B-induced microglial and neuronal IL-1 expression is mediated by cell type-specific transcription factors. Journal of Neurochemistry. 92: 546-53. PMID 15659225 DOI: 10.1111/J.1471-4159.2004.02909.X  0.169
1982 Griffin WS, Snider BJ, Morrison MR. Normalization of cerebellar RNA synthesis and mRNA levels after treatment of graft versus host disease. Journal of Neurochemistry. 39: 1412-7. PMID 6181206  0.168
1996 Graham DI, Gentleman SM, Nicoll JA, Royston MC, McKenzie JE, Roberts GW, Griffin WS. Altered beta-APP metabolism after head injury and its relationship to the aetiology of Alzheimer's disease. Acta Neurochirurgica. Supplement. 66: 96-102. PMID 8780805  0.168
1999 Royston MC, McKenzie JE, Gentleman SM, Sheng JG, Mann DM, Griffin WS, Mrak RE. Overexpression of s100beta in Down's syndrome: correlation with patient age and with beta-amyloid deposition. Neuropathology and Applied Neurobiology. 25: 387-93. PMID 10564528  0.168
2008 Shaftel SS, Griffin WS, O'Banion MK. The role of interleukin-1 in neuroinflammation and Alzheimer disease: an evolving perspective. Journal of Neuroinflammation. 5: 7. PMID 18302763 DOI: 10.1186/1742-2094-5-7  0.167
1996 Sheng JG, Ito K, Skinner RD, Mrak RE, Rovnaghi CR, Van Eldik LJ, Griffin WS. In vivo and in vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer pathogenesis. Neurobiology of Aging. 17: 761-6. PMID 8892349 DOI: 10.1016/0197-4580(96)00104-2  0.167
2000 Grimaldi LM, Casadei VM, Ferri C, Veglia F, Licastro F, Annoni G, Biunno I, De Bellis G, Sorbi S, Mariani C, Canal N, Griffin WS, Franceschi M. Association of early-onset Alzheimer's disease with an interleukin-1alpha gene polymorphism. Annals of Neurology. 47: 361-5. PMID 10716256  0.166
2001 Li Y, Liu L, Barger SW, Mrak RE, Griffin WS. Vitamin E suppression of microglial activation is neuroprotective. Journal of Neuroscience Research. 66: 163-70. PMID 11592111 DOI: 10.1002/Jnr.1208  0.165
1993 Border BG, Lin SC, Griffin WS, Pardue S, Morrison-Bogorad M. Alterations in actin-binding beta-thymosin expression accompany neuronal differentiation and migration in rat cerebellum. Journal of Neurochemistry. 61: 2104-14. PMID 8245965 DOI: 10.1111/J.1471-4159.1993.Tb07448.X  0.161
2015 Zawada WM, Mrak RE, Biedermann J, Palmer QD, Gentleman SM, Aboud O, Griffin WS. Loss of angiotensin II receptor expression in dopamine neurons in Parkinson's disease correlates with pathological progression and is accompanied by increases in Nox4- and 8-OH guanosine-related nucleic acid oxidation and caspase-3 activation. Acta Neuropathologica Communications. 3: 9. PMID 25645462 DOI: 10.1186/S40478-015-0189-Z  0.159
2000 Du Y, Dodel RC, Eastwood BJ, Bales KR, Gao F, Lohmüller F, Müller U, Kurz A, Zimmer R, Evans RM, Hake A, Gasser T, Oertel WH, Griffin WS, Paul SM, et al. Association of an interleukin 1 alpha polymorphism with Alzheimer's disease. Neurology. 55: 480-3. PMID 10953177 DOI: 10.1212/Wnl.55.4.480  0.157
2006 Griffin WS. Inflammation and neurodegenerative diseases. The American Journal of Clinical Nutrition. 83: 470S-474S. PMID 16470015  0.148
1997 Castets F, Griffin WS, Marks A, Van Eldik LJ. Transcriptional regulation of the human S100 beta gene. Brain Research. Molecular Brain Research. 46: 208-16. PMID 9191095 DOI: 10.1016/S0169-328X(96)00298-7  0.145
2000 Nicoll JA, Mrak RE, Graham DI, Stewart J, Wilcock G, MacGowan S, Esiri MM, Murray LS, Dewar D, Love S, Moss T, Griffin WS. Association of interleukin-1 gene polymorphisms with Alzheimer's disease. Annals of Neurology. 47: 365-8. PMID 10716257 DOI: 10.1002/1531-8249(200003)47:3<365::Aid-Ana13>3.0.Co;2-G  0.141
1980 Griffin WS, Head JR, Pardue S, Morrison MR. Changes in RNA synthesis and messenger RNA content in the cerebellum of rats with graft versus host disease. Journal of Neurochemistry. 35: 880-8. PMID 6161231  0.139
1993 Karson CN, Casanova MF, Kleinman JE, Griffin WS. Choline acetyltransferase in schizophrenia. The American Journal of Psychiatry. 150: 454-9. PMID 8434662  0.139
1994 Stanley LC, Mrak RE, Woody RC, Perrot LJ, Zhang S, Marshak DR, Nelson SJ, Griffin WS. Glial cytokines as neuropathogenic factors in HIV infection: pathogenic similarities to Alzheimer's disease. Journal of Neuropathology and Experimental Neurology. 53: 231-8. PMID 8176406 DOI: 10.1097/00005072-199405000-00003  0.138
1981 Griffin WS, Head JR, Morrison MR. Graft-versus-host disease (GVHD) and immunotherapy: effects on basic cell functions in the developing brain. Transplantation Proceedings. 13: 1237-40. PMID 7268888  0.137
1995 Lyle RE, Tryka AF, Griffin WS, Taylor BJ. Tryptase immunoreactive mast cell hyperplasia in bronchopulmonary dysplasia. Pediatric Pulmonology. 19: 336-43. PMID 7567212  0.137
1987 Chronwall BM, Millington WR, Griffin WS, Unnerstall JR, O'Donohue TL. Histological evaluation of the dopaminergic regulation of proopiomelanocortin gene expression in the intermediate lobe of the rat pituitary, involving in situ hybridization and [3H]thymidine uptake measurement. Endocrinology. 120: 1201-11. PMID 3803315 DOI: 10.1210/endo-120-3-1201  0.134
1996 Karson CN, Griffin WS, Mrak RE, Husain M, Dawson TM, Snyder SH, Moore NC, Sturner WQ. Nitric oxide synthase (NOS) in schizophrenia: increases in cerebellar vermis. Molecular and Chemical Neuropathology / Sponsored by the International Society For Neurochemistry and the World Federation of Neurology and Research Groups On Neurochemistry and Cerebrospinal Fluid. 27: 275-84. PMID 9147413 DOI: 10.1007/Bf02815109  0.129
1985 Head JR, Griffin WS. Functional capacity of solid tissue transplants in the brain: evidence for immunological privilege. Proceedings of the Royal Society of London. Series B, Biological Sciences. 224: 375-87. PMID 2862633  0.129
2005 Mrak RE, Griffin WS. Glia and their cytokines in progression of neurodegeneration. Neurobiology of Aging. 26: 349-54. PMID 15639313 DOI: 10.1016/j.neurobiolaging.2004.05.010  0.129
2000 Komoroski R, Pearce J, Griffin W, Mrak R, Karson C, Omori M. 65. 31P NMR of phospholipids in postmortem schizophrenic brains Biological Psychiatry. 47: S20. DOI: 10.1016/S0006-3223(00)00327-9  0.127
1989 Ginzburg I, Behar L, Littauer UZ, Griffin WS. Differential localization of microtubules in cerebellar cells. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 9: 1961-7. PMID 2723760 DOI: 10.1523/Jneurosci.09-06-01961.1989  0.125
1986 Ginzburg I, Teichman A, Griffin WS, Littauer UZ. Differential expression of alpha-tubulin mRNA in rat cerebellum as revealed by in situ hybridization. Febs Letters. 194: 161-4. PMID 3753592 DOI: 10.1016/0014-5793(86)80069-2  0.123
2007 Chen Y, Bodles AM, McPhie DL, Neve RL, Mrak RE, Griffin WS. APP-BP1 inhibits Abeta42 levels by interacting with Presenilin-1. Molecular Neurodegeneration. 2: 3. PMID 17286867 DOI: 10.1186/1750-1326-2-3  0.119
1979 Griffin WS, Head JR, Pacheco MF. Cerebellar morphology: alterations during graft versus host disease. Brain Research Bulletin. 4: 313-7. PMID 39664  0.116
2004 Wainwright MS, Craft JM, Griffin WS, Marks A, Pineda J, Padgett KR, Van Eldik LJ. Increased susceptibility of S100B transgenic mice to perinatal hypoxia-ischemia. Annals of Neurology. 56: 61-7. PMID 15236402 DOI: 10.1002/Ana.20142  0.114
2007 Kölsch H, Larionov S, Dedeck O, Orantes M, Birkenmeier G, Griffin WS, Thal DR. Association of the glutathione S-transferase omega-1 Ala140Asp polymorphism with cerebrovascular atherosclerosis and plaque-associated interleukin-1 alpha expression. Stroke; a Journal of Cerebral Circulation. 38: 2847-50. PMID 17717316 DOI: 10.1161/STROKEAHA.107.484162  0.113
1985 Griffin WS, Alejos MA, Cox EJ, Morrison MR. The differential distribution of beta tubulin mRNAs in individual mammalian brain cells. Journal of Cellular Biochemistry. 27: 205-14. PMID 2859294 DOI: 10.1002/jcb.240270303  0.109
2013 Topchiy E, Panzhinskiy E, Griffin WS, Barger SW, Das M, Zawada WM. Nox4-generated superoxide drives angiotensin II-induced neural stem cell proliferation. Developmental Neuroscience. 35: 293-305. PMID 23751520 DOI: 10.1159/000350502  0.106
2004 Gentleman SM, Leclercq PD, Moyes L, Graham DI, Smith C, Griffin WS, Nicoll JA. Long-term intracerebral inflammatory response after traumatic brain injury. Forensic Science International. 146: 97-104. PMID 15542269 DOI: 10.1016/J.Forsciint.2004.06.027  0.105
2001 Komoroski RA, Pearce JM, Griffin WS, Mrak RE, Omori M, Karson CN. Phospholipid abnormalities in postmortem schizophrenic brains detected by 31P nuclear magnetic resonance spectroscopy: a preliminary study. Psychiatry Research. 106: 171-80. PMID 11382539 DOI: 10.1016/S0925-4927(01)00081-6  0.104
1999 Karson CN, Mrak RE, Schluterman KO, Sturner WQ, Sheng JG, Griffin WS. Alterations in synaptic proteins and their encoding mRNAs in prefrontal cortex in schizophrenia: a possible neurochemical basis for 'hypofrontality'. Molecular Psychiatry. 4: 39-45. PMID 10089007  0.102
1983 Griffin W, Morrison M. Immunohistochemistry and in situ hybridization: new tools for analyzing the expression of mRNAS in individual brain cells International Journal of Developmental Neuroscience. 1: 216-216. DOI: 10.1016/0736-5748(83)90284-8  0.098
1998 Griffin WS, Sheng JG, Mrak RE. Senescence-accelerated overexpression of S100beta in brain of SAMP6 mice. Neurobiology of Aging. 19: 71-6. PMID 9562506  0.096
2013 Smith C, Gentleman SM, Leclercq PD, Murray LS, Griffin WS, Graham DI, Nicoll JA. The neuroinflammatory response in humans after traumatic brain injury. Neuropathology and Applied Neurobiology. 39: 654-66. PMID 23231074 DOI: 10.1111/Nan.12008  0.091
1983 Morrison MR, Pardue S, Griffin WS. Altered expression of different tubulin electrophoretic variants during human cortex development. Journal of Neurogenetics. 1: 105-11. PMID 6085633  0.09
1981 Morrison MR, Griffin WS. ALTERATIONS IN TUBULIN mRNA LEVELS IN THE DEVELOPING RAT CEREBELLUM Biochemical Society Transactions. 9: 278P-278P. DOI: 10.1042/bst009278pa  0.09
1981 Morrison MR, Pardue S, Griffin WS. Developmental alterations in the levels of translationally active messenger RNAs in the postnatal rat cerebellum. The Journal of Biological Chemistry. 256: 3550-6. PMID 7204410  0.088
1981 Morrison MR, Griffin WS. The isolation and in vitro translation of undegraded messenger RNAs from human postmortem brain. Analytical Biochemistry. 113: 318-24. PMID 7283137  0.087
2004 Mrak RE, Griffin WS. Trisomy 21 and the brain. Journal of Neuropathology and Experimental Neurology. 63: 679-85. PMID 15290893  0.087
2005 Freeman T, Roca V, Guggenheim F, Kimbrell T, Griffin WS. Neuropsychiatric associations of apolipoprotein E alleles in subjects with combat-related posttraumatic stress disorder. The Journal of Neuropsychiatry and Clinical Neurosciences. 17: 541-3. PMID 16387995 DOI: 10.1176/appi.neuropsych.17.4.541  0.083
1985 Griffin WS, Morrison MR. In situ hybridization--visualization and quantitation of genetic expression in mammalian brain. Peptides. 6: 89-96. PMID 2417210  0.074
1987 Griffin WS, Lonsberry LM. Graft-versus-host disease: a model for studying the neural regulation of immune function. Transplantation Proceedings. 19: 1130. PMID 3274293  0.072
1986 Morrison MR, Griffin WS. Quantitation and in situ localization of tubulin mRNA in the mammalian nervous system. Annals of the New York Academy of Sciences. 466: 51-74. PMID 3460428  0.067
1981 Parker CR, Griffin WS, Porter JC. Age-dependent extinction of thyrotropin-releasing hormone in the human cerebellum. The Journal of Clinical Endocrinology and Metabolism. 53: 1233-7. PMID 6795225 DOI: 10.1210/jcem-53-6-1233  0.063
1997 Omori M, Pearce J, Komoroski RA, Griffin WS, Mrak RE, Husain MM, Karson CN. In vitro 1H-magnetic resonance spectroscopy of postmortem brains with schizophrenia. Biological Psychiatry. 42: 359-66. PMID 9276076 DOI: 10.1016/S0006-3223(96)00409-X  0.052
1978 Griffin WS, Wildenthal K. Myofibrillar alkaline protease activity in rat heart and its responses to some interventions that alter cardiac size. Journal of Molecular and Cellular Cardiology. 10: 669-76. PMID 151150  0.046
1997 Mrak RE, Griffin WS. The role of chronic self-propagating glial responses in neurodegeneration: implications for long-lived survivors of human immunodeficiency virus. Journal of Neurovirology. 3: 241-6. PMID 9291232  0.046
2022 Litzelman DK, Umoren RA, Inui TS, Griffin W, Perkins SM, Moser EA, Wiehe SE, Roth S, DeChant P, Swigonski NL. Evaluation of a Program to Reduce Infant Mortality Risk Factors in Central Indiana. Journal of Health Care For the Poor and Underserved. 33: 1461-1477. PMID 36245175 DOI: 10.1353/hpu.2022.0124  0.039
2023 Yakovlyeva A, Griffin W, Worden A, Roth S, DeChant P, Butler D, Tang Q, Litzelman DK. Racial Differences in Retention in a Community-based Addiction Reduction Program Implemented by Peer Recovery Coaches for Women of Reproductive Age. Inquiry : a Journal of Medical Care Organization, Provision and Financing. 60: 469580231218644. PMID 38145320 DOI: 10.1177/00469580231218644  0.026
2016 Litzelman DK, Cottingham AH, Griffin W, Inui TS, Ivy SS. Enhancing the prospects for palliative care at the end of life: A statewide educational demonstration project to improve advance care planning. Palliative & Supportive Care. 1-11. PMID 27320687 DOI: 10.1017/S1478951516000353  0.026
1976 Culick FEC, Shen PI, Griffin WS. Acoustic Waves and Heating Due to Molecular Energy Transfer in an Electric Discharge CO Laser Ieee Journal of Quantum Electronics. 12: 566-574. DOI: 10.1109/Jqe.1976.1069042  0.025
1996 Karson CN, Mrak RE, Husain MM, Griffin WS. Decreased mesopontine choline acetyltransferase levels in schizophrenia. Correlations with cognitive functions. Molecular and Chemical Neuropathology / Sponsored by the International Society For Neurochemistry and the World Federation of Neurology and Research Groups On Neurochemistry and Cerebrospinal Fluid. 29: 181-91. PMID 8971695 DOI: 10.1007/BF02815001  0.02
1974 Biricikoglu V, Griffin WS. RESPONSE OF COOLED METAL MIRRORS TO HIGH POWER LASER PULSES American Society of Mechanical Engineers (Paper) 0.012
2004 Mrak RE, Griffin WS. Funding free and universal access to Journal of Neuroinflammation. Journal of Neuroinflammation. 1: 19. PMID 15485579 DOI: 10.1186/1742-2094-1-19  0.011
2004 Mrak RE, Griffin WS. Welcome to the Journal of Neuroinflammation! Journal of Neuroinflammation. 1: 1. PMID 15285806 DOI: 10.1186/1742-2094-1-1  0.01
1999 Griffin WS. Evolution of the global decommissioning regulatory regime Spe Production and Facilities. 14: 83-87.  0.01
1996 Griffin WS. Decommissioning around the world Petroleum Review. 50.  0.01
1989 Hoyle BJ, Griffin WS. International standards for removal of abandoned and disused offshore oil production platforms: negotiation and agreement Otc '89, Proc. 21st Annual Offshore Technology Conf., Houston, U.S.a., May 1-4, 1989, Richardson, U.S.a., Offshore Technology. 1: 503-509.  0.01
1977 Mueller EA, Griffin WS, Wildenthal K. Isoproterenol-induced cardiomyopathy: changes in cardiac enzymes and protection by methylprednisolone. Journal of Molecular and Cellular Cardiology. 9: 565-78. PMID 894732  0.01
1975 Cohn DB, Griffin WS, Mendoza PJ. Improved convective flow longitudinal discharge CO laser Journal of Applied Physics. 46: 2790. DOI: 10.1063/1.321960  0.01
Hide low-probability matches.